{
    "nct_id": "NCT04346316",
    "official_title": "A Randomized, Double Blind and Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of SHR0302 Tablets in Adult Patients With Alopecia Areata",
    "inclusion_criteria": "* Male or female subjects between 18-65 years of age (both inclusive), at the time of informed consent;\n* Must have moderate to severe alopecia areata.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* Other types of alopecia or other diseases that can cause hair loss\n* Other scalp diseases that could interfere with assessment of hair loss/regrowth\n* Any previous use of any Janus kinase (JAK) inhibitor",
    "miscellaneous_criteria": ""
}